ABSTRACT
Corneal neovascularization (CoNV) is a sight-threatening condition affecting an estimated 1.4 million people per year, and the incidence is expected to rise. It is a complication of corneal pathological diseases such as infective keratitis, chemical burn, corneal limbal stem cell deficiency, mechanical trauma, and immunological rejection after keratoplasties. CoNV occurs due to a disequilibrium in proangiogenic and antiangiogenic mediators, involving a complex system of molecular interactions. Treatment of CoNV is challenging, and no therapy thus far has been curative. Anti-inflammatory agents such as corticosteroids are the mainstay of treatment due to their accessibility and well-studied safety profile. However, they have limited effectiveness and are unable to regress more mature neovascularization. With the advent of advanced imaging modalities and an expanding understanding of its pathogenesis, contemporary treatments targeting a wide array of molecular mechanisms and surgical options are gaining traction. This review aims to summarize evidence regarding conventional and emerging therapeutic options for CoNV.
Subject(s)
Corneal Neovascularization , Humans , Corneal Neovascularization/diagnosis , Corneal Neovascularization/therapy , Corneal Neovascularization/etiology , Angiogenesis Inhibitors/therapeutic use , Disease ManagementABSTRACT
Corneal neovascularization is one of the most common causes of decreased visual acuity and disability for vision loss, increase in the risk of corneal graft rejection, and appearance of opacifications on the cornea. This article reviews literature on etiological factors of the development of corneal neovascularization, as well as modern methods of diagnosis, conservative and surgical treatment of this pathology.
Subject(s)
Corneal Diseases , Corneal Neovascularization , Humans , Corneal Neovascularization/diagnosis , Corneal Neovascularization/etiology , Corneal Neovascularization/therapy , CorneaABSTRACT
Corneal neovascularization (CoNV), a pathological form of angiogenesis, involves the growth of blood and lymph vessels into the avascular cornea from the limbus and adversely affects transparency and vision. Alkali burn is one of the most common forms of ocular trauma that leads to CoNV. In this protocol, CoNV is experimentally induced using sodium hydroxide solution in a controlled manner to ensure reproducibility. The alkali burn model is useful for understanding the pathology of CoNV and can be extended to study angiogenesis in general because of the avascularity, transparency, and accessibility of the cornea. In this work, CoNV was analyzed by direct examination under a dissecting microscope and by immunostaining flat-mount corneas using anti-CD31 mAb. Lymphangiogenesis was detected on flat-mount corneas by immunostaining using anti-LYVE-1 mAb. Corneal edema was visualized and quantified using optical coherence tomography (OCT). In summary, this model will help to advance existing neovascularization assays and discover new treatment strategies for pathologic ocular and extraocular angiogenesis.
Subject(s)
Burns, Chemical , Corneal Diseases , Corneal Neovascularization , Mice , Animals , Corneal Neovascularization/etiology , Corneal Neovascularization/pathology , Corneal Neovascularization/therapy , Burns, Chemical/complications , Burns, Chemical/pathology , Reproducibility of Results , Cornea/pathology , Neovascularization, Pathologic/pathology , Corneal Diseases/pathology , Disease Models, AnimalABSTRACT
RESUMO A ceratopigmentação teve seu primeiro registro pelo filósofo Galeno há muitos séculos como uma estratégia utilizada para o tratamento estético de pacientes com leucomas. As córneas com leucoma são patológicas e, muitas vezes, intolerantes a lentes de contato cosméticas ou próteses oculares, sendo comum a queixa de desconforto excessivo, proporcionado pela superfície corneana irregular. Assim, a ceratopigmentação é uma alternativa para a melhora estética de pacientes com opacidades corneanas. Descrevemos o caso de um paciente do sexo masculino, 39 anos, que apresentou despigmentação precoce em caso de ceratopigmentação associado a quadro de ceratite herpética necrotizante. O paciente foi submetido ao tratamento com aciclovir 2g ao dia e doxiciclina 200mg ao dia, evoluindo com melhora do quadro clínico, apesar da má adesão medicamentosa.
ABSTRACT Keratopigmentation was first recorded many centuries ago by the philosopher Galeno, as a strategy used for the aesthetic treatment of patients with leukomas. Corneas with leucoma are pathological and often intolerant of cosmetic contact lenses or ocular prostheses, with complaints of excessive discomfort provided by the irregular corneal surface being common. Therefore, keratopigmentation is an alternative for the aesthetic improvement of patients with corneal opacities. We describe the case of a 39-year old male patient, who presented early depigmentation in a case of keratopigmentation associated with necrotizing herpetic keratitis. The patient was treated with Acyclovir 2g/day and Doxycycline 200mg/day, evolving with clinical improvement, despite poor medication adherence.
Subject(s)
Humans , Male , Adult , Tattooing/methods , Corneal Neovascularization/etiology , Cornea/surgery , Corneal Opacity/surgery , Coloring Agents/adverse effects , Acyclovir/administration & dosage , Eye Injuries/complications , Cosmetic Techniques , Patient Satisfaction , Keratitis, Herpetic/drug therapy , Doxycycline/administration & dosage , Corneal Opacity/etiology , EstheticsABSTRACT
Microbiota promotes or inhibits the pathogenesis of a range of immune-mediated disorders. Although recent studies have elucidated the role of gut microbiota in ocular disease, the effect of ocular microbiota remains unclear. Herein, we explored the role of ocular commensal bacteria in non-infectious corneal inflammation and angiogenesis in a mouse model of suture-induced corneal neovascularization. Results revealed that the ocular surface harbored a microbial community consisting mainly of Actinobacteria, Firmicutes and Proteobacteria. Elimination of the ocular commensal bacteria by oral broad-spectrum antibiotics or topical fluoroquinolone significantly suppressed corneal inflammation and neovascularization. Disease amelioration was associated with reduced numbers of CD11b+Ly6C+ and CD11b+Ly6G+ myeloid cells, not Foxp3+ regulatory T cells, in the spleen, blood, and draining lymph nodes. Therapeutic concentrations of fluoroquinolone, however, did not directly affect immune cells or vascular endothelial cells. In addition, data from a clinical study showed that antibiotic treatment in combination with corticosteroids, as compared with corticosteroid monotherapy, induced faster remission of corneal inflammation and new vessels in pediatric patients with non-infectious marginal keratitis. Altogether, our findings demonstrate a pathogenic role of ocular microbiota in non-infectious inflammatory disorders leading to sight-threatening corneal neovascularization, and suggest a therapeutic potential of targeting commensal microbes in treating ocular inflammation.
Subject(s)
Corneal Neovascularization , Keratitis , Microbiota , Mice , Animals , Corneal Neovascularization/drug therapy , Corneal Neovascularization/etiology , Corneal Neovascularization/pathology , Endothelial Cells , Keratitis/drug therapy , Keratitis/complications , Neovascularization, Pathologic/complications , Neovascularization, Pathologic/pathology , Inflammation/pathology , Cornea/pathology , Fluoroquinolones/therapeutic useABSTRACT
The aim of this study was to analyze the single and combined effects of N-acetyl cysteine (NAC) and doxycycline (Dox) on the inflammatory and angiogenic factors in the rat model of alkali-burned cornea. Rats were treated with a single and combined 0.5% NAC and 12.5 µg/mL Dox eye drops and evaluated on days 3, 7, and 28. In the corneas of various groups, the activity of Catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx) enzymes was assessed. The expression of inflammatory factors (TNF-α, Rel-a, and CXCL-1) and angiogenic factors (VEGF-a, MMP2, and MMP9) was measured using real-time polymerase chain reaction. The antioxidant enzyme activities decreased substantially 3 days after injury with sodium hydroxide (NaOH). NAC and combined NAC+ Dox topical treatments increased the SOD enzyme activity on day 28 (P < 0.05). The expression of TNF-α and Rel-a genes following single and combined treatment of NAC and Dox decreased significantly on days 7 and 28 (P < 0.05). The mRNA level of angiogenic factors and corneal neovascularization (CNV) level declined in NaOH-injured rats treated with Dox (P < 0.05). The topical treatment of Dox could attenuate inflammation and CNV complications. However, NAC treatment may not reduce the expression of angiogenic genes.
Subject(s)
Burns, Chemical , Corneal Neovascularization , Eye Burns , Acetylcysteine/metabolism , Acetylcysteine/pharmacology , Alkalies/metabolism , Alkalies/pharmacology , Angiogenesis Inducing Agents/metabolism , Angiogenesis Inducing Agents/pharmacology , Animals , Burns, Chemical/complications , Burns, Chemical/drug therapy , Burns, Chemical/metabolism , Cornea/metabolism , Corneal Neovascularization/etiology , Corneal Neovascularization/genetics , Disease Models, Animal , Doxycycline/metabolism , Doxycycline/pharmacology , Eye Burns/chemically induced , Eye Burns/complications , Eye Burns/drug therapy , Rats , Sodium Hydroxide/metabolism , Sodium Hydroxide/pharmacology , Superoxide Dismutase/metabolism , Tumor Necrosis Factor-alpha/metabolismABSTRACT
BACKGROUND: The purpose of this study was to evaluate the incidence, timing and risk factors of corneal neovascularisation (NV) after deep anterior lamellar keratoplasty (DALK) for corneal ectasia. METHODS: This study included 616 eyes who underwent DALK between 2012 and 2020 in two tertiary referral centres. In one centre topical corticosteroids were discontinued after complete suture removal 1 year after surgery, whereas in the other they were discontinued 3-4 months after surgery. The presence and severity of corneal NV was ascertained based on slit lamp photographs. Potential risk factors for corneal NV were evaluated using the Cox proportional hazards model. RESULTS: The cumulative incidence of corneal NV was 8.7% at 1 year after surgery and 13.2% at 5 years. Mean time interval from surgery to development of corneal NV was 12.8±16.2 months, with 68.9% of cases occurring before complete suture removal. Early discontinuation of topical steroids, older age and ocular allergy were associated with an increased risk of developing corneal NV (respectively, HR=2.625, HR=1.019, HR=3.726, all p<0.05). CONCLUSIONS: The risk of corneal NV is higher in the first year following DALK. Early discontinuation of topical steroids, ocular allergy and older age are significant predictors of corneal NV.
Subject(s)
Corneal Neovascularization , Corneal Transplantation , Hypersensitivity , Keratoconus , Adrenal Cortex Hormones , Cornea/surgery , Corneal Neovascularization/diagnosis , Corneal Neovascularization/epidemiology , Corneal Neovascularization/etiology , Corneal Transplantation/adverse effects , Dilatation, Pathologic , Humans , Hypersensitivity/etiology , Hypersensitivity/surgery , Incidence , Keratoconus/surgery , Keratoplasty, Penetrating , Retrospective Studies , Risk Factors , Steroids , Visual AcuityABSTRACT
PURPOSE: Corneal injury may cause neovascularization and lymphangiogenesis in cornea which have a detrimental effect to vision and even lead to blindness. Bone morphogenetic protein 4 (BMP4) regulates a variety of biological processes, which is closely relevant to the regulation of corneal epithelium and angiogenesis. Herein, we aimed to evaluate the effect of BMP4 on corneal neovascularization (CNV), corneal lymphangiogenesis (CL), corneal epithelial repair, and the role of BMP4/Smad pathway in these processes. METHODS: We used MTT assay to determine the optimal concentration of BMP4. The suture method was performed to induce rat CNV and CL. We used ink perfusion and HE staining to visualize the morphological change of CNV, and utilized RT-qPCR and ELISA to investigate the expression of angiogenic factors and lymphangiogenic factors. The effects of BMP4 and anti-VEGF antibody on migration, proliferation and adhesion of corneal epithelium were determined by scratch test, MTT assay and cell adhesion test. RESULTS: BMP4 significantly inhibited CNV and possibly CL. Topical BMP4 resulted in increased expression of endogenous BMP4, and decreased expression of angiogenic factors and lymphangiogenic factors. Compared with anti-VEGF antibody, BMP4 enhanced corneal epithelium migration, proliferation and adhesion, which facilitated corneal epithelial injury repair. Simultaneously, these processes could be regulated by BMP4/Smad pathway. CONCLUSIONS: Our results demonstrated unreported effects of BMP4 on CNV, CL, and corneal epithelial repair, suggesting that BMP4 may represent a potential therapeutic target in corneal injury repair.
Subject(s)
Bone Morphogenetic Protein 4/genetics , Corneal Injuries/genetics , Corneal Neovascularization/etiology , Corneal Stroma/pathology , Gene Expression Regulation , RNA/genetics , Wound Healing , Animals , Bone Morphogenetic Protein 4/biosynthesis , Cell Movement , Cell Proliferation , Cells, Cultured , Corneal Injuries/complications , Corneal Injuries/pathology , Corneal Neovascularization/genetics , Corneal Neovascularization/pathology , Corneal Stroma/metabolism , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Female , RNA/metabolism , Rats , Rats, WistarABSTRACT
The cornea, while appearing to be simple tissue, is actually an extremely complex structure. In order for it to retain its biomechanical and optical properties, perfect organization of its cells is essential. Proper regeneration is especially important after injuries and in the course of various diseases. Eph receptors and ephrin are mainly responsible for the proper organization of tissues as well as cell migration and communication. In this review, we present the current state of knowledge on the role of Eph and ephrins in corneal physiology and diseases, in particular, we focused on the functions of the epithelium and endothelium. Since the role of Eph and ephrins in the angiogenesis process has been well established, we also analyzed their influence on conditions with corneal neovascularization.
Subject(s)
Cornea/physiology , Corneal Diseases/etiology , Ephrins/physiology , Receptors, Eph Family/physiology , Animals , Corneal Diseases/drug therapy , Corneal Neovascularization/etiology , Endothelium, Corneal/pathology , Endothelium, Corneal/physiology , Epithelium, Corneal/pathology , Epithelium, Corneal/physiology , Humans , Molecular Targeted TherapyABSTRACT
The present study aimed to demonstrate the possibility to treat corneal neovascularization using the combination of anti-VEGF injection and argon laser photocoagulation.
Subject(s)
Corneal Neovascularization , Angiogenesis Inhibitors , Argon , Corneal Neovascularization/diagnosis , Corneal Neovascularization/drug therapy , Corneal Neovascularization/etiology , Humans , Laser Coagulation , Lasers , Neovascularization, Pathologic/therapyABSTRACT
OBJECTIVE: The calcineurin-NFAT (nuclear factor for activated T cells)-DSCR (Down syndrome critical region)-1 pathway plays a crucial role as the downstream effector of VEGF (vascular endothelial growth factor)-mediated tumor angiogenesis in endothelial cells. A role for DSCR-1 in different organ microenvironment such as the cornea and its role in ocular diseases is not well understood. Corneal changes can be indicators of various disease states and are easily detected through ocular examinations. Approach and Results: The presentation of a corneal arcus or a corneal opacity due to lipid deposition in the cornea often indicates hyperlipidemia and in most cases, hypercholesterolemia. Although the loss of Apo (apolipoprotein) E has been well characterized and is known to lead to elevated serum cholesterol levels, there are few corneal changes observed in ApoE-/- mice. In this study, we show that the combined loss of ApoE and DSCR-1 leads to a dramatic increase in serum cholesterol levels and severe corneal opacity with complete penetrance. The cornea is normally maintained in an avascular state; however, loss of Dscr-1 is sufficient to induce hyper-inflammatory and -oxidative condition, increased corneal neovascularization, and lymphangiogenesis. Furthermore, immunohistological analysis and genome-wide screening revealed that loss of Dscr-1 in mice triggers increased immune cell infiltration and upregulation of SDF (stromal derived factor)-1 and its receptor, CXCR4 (C-X-C motif chemokine ligand receptor-4), potentiating this signaling axis in the cornea, thereby contributing to pathological corneal angiogenesis and opacity. CONCLUSIONS: This study is the first demonstration of the critical role for the endogenous inhibitor of calcineurin, DSCR-1, and pathological corneal angiogenesis in hypercholesterolemia induced corneal opacity.
Subject(s)
Calcium-Binding Proteins/deficiency , Corneal Neovascularization/etiology , Corneal Opacity/etiology , Endothelial Cells/metabolism , Endothelium, Corneal/metabolism , Hypercholesterolemia/complications , Muscle Proteins/deficiency , Animals , Calcium-Binding Proteins/genetics , Chemokine CXCL12/metabolism , Chemotaxis, Leukocyte , Corneal Neovascularization/genetics , Corneal Neovascularization/metabolism , Corneal Neovascularization/pathology , Corneal Opacity/genetics , Corneal Opacity/metabolism , Corneal Opacity/pathology , DNA-Binding Proteins/metabolism , Disease Models, Animal , Disease Progression , Endothelial Cells/pathology , Endothelium, Corneal/pathology , Eye Infections, Fungal/metabolism , Eye Infections, Fungal/pathology , HEK293 Cells , Humans , Hypercholesterolemia/genetics , Hypercholesterolemia/metabolism , Lymphangiogenesis , Male , Mice, Inbred C57BL , Mice, Knockout, ApoE , Muscle Proteins/genetics , Muscle Proteins/metabolism , Oxidative Stress , Receptors, CXCR4/metabolism , Signal Transduction , Stevens-Johnson Syndrome/metabolism , Stevens-Johnson Syndrome/pathology , Time Factors , Vascular Endothelial Growth Factor A/metabolismABSTRACT
BACKGROUND: Corneal neovascularization (CN) is a clue feature of different ocular pathological conditions and can lead to corneal edema and opacification with subsequent vision loss. Vascular endothelial growth factor (VEGF), which plays a key role in new vessels formation, proliferation and migration, was found to be up-regulated in these conditions. Nowadays, it is possible to downregulate the angiogenic process by using anti-VEGF agents administered by different routes. OBJECTIVE: To evaluate the efficacy, safety and possible future directions of anti-VEGF agents used for the treatment of CNV owing to different aetiologies. METHODS: A computerized search of articles dealing with the topic of anti-VEGF therapy in CN was conducted in PubMed, Scopus and Medline electronic databases. The following key phrases were used: anti-VEGF agents, corneal neovascularization, bevacizumab, ranibizumab, vascular endothelial growth factor, angiogenesis. RESULTS: The use of anti-VEGF therapy in the treatment of CN reduced pathological vessel density without causing significant side effects. Various administration routes such as topical, subconjunctival and intrastromal ones are available, and the choice depends on patient and disease characteristics. Much more effectiveness is achieved in case of early administration before mature and wellestablished vessels take place. A combined approach between various drugs including anti-VEGF agents should be adopted in those cases at higher risk of neovascularization recurrence such as chronic long-standing diseases where ischemic and inflammatory stimuli are not definitively reversed. CONCLUSION: The efficacy and safety of anti-VEGF agents support their adoption into the daily clinical practice for the management of CN.
Subject(s)
Angiogenesis Inhibitors/therapeutic use , Corneal Diseases/drug therapy , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Angiogenesis Inhibitors/adverse effects , Animals , Clinical Trials as Topic , Corneal Diseases/etiology , Corneal Diseases/metabolism , Corneal Diseases/pathology , Corneal Neovascularization/drug therapy , Corneal Neovascularization/etiology , Corneal Neovascularization/metabolism , Corneal Neovascularization/pathology , Humans , Neovascularization, PathologicABSTRACT
Blood vessels and nerves travel together to supply most tissues in the body. However, there is a knowledge gap in the mechanisms underlying the direct regulation of angiogenesis by nerves. In the current study, we examined the regulation of angiogenesis by sensory nerves in response to inflammation using the cornea, a normally avascular and densely innervated ocular tissue, as a model. We used desiccating stress as an inflammatory stimulus in vivo and found that sub-basal and epithelial nerve densities in the cornea were reduced in dry eye disease (DED). We established a co-culture system of trigeminal ganglion sensory neurons and vascular endothelial cells (VEC) and found that neurons isolated from mice with DED directly promoted VEC proliferation and tube formation compared with normal controls. In addition, these neurons expressed and secreted higher levels of substance P (SP), a proinflammatory neuropeptide. SP potently promoted VEC activation in vitro and blockade of SP signaling with spantide I, an antagonist of SP receptor Neurokinin-1, significantly reduced corneal neovascularization in vivo. Spantide I and siRNA knockdown of SP abolished the promotion of VEC activation by DED neurons in vitro. Taken together, our data suggested that sensory neurons directly promote angiogenesis via SP signaling in response to inflammation in the cornea.
Subject(s)
Corneal Neovascularization/pathology , Dry Eye Syndromes/pathology , Endothelial Cells/pathology , Inflammation/complications , Receptors, Neurokinin-1/metabolism , Sensory Receptor Cells/pathology , Substance P/metabolism , Animals , Corneal Neovascularization/etiology , Corneal Neovascularization/metabolism , Dry Eye Syndromes/etiology , Dry Eye Syndromes/metabolism , Endothelial Cells/metabolism , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Sensory Receptor Cells/metabolism , Signal TransductionABSTRACT
PURPOSE: To investigate whether subconjunctival bevacizumab help prevent corneal graft neovascularization and prolong the graft survival of patients with chemical burns. METHODS: We performed a prospective nonrandomized comparative case series study. Twenty-six eyes received subconjunctival bevacizumab (10 mg/0.4 mL) once and topical immunosuppressive agents after sclerocorneal lamellar keratoplasty as the treatment, and 13 eyes received a topical immunosuppressant alone and served as the control group. The main outcomes were a cumulative probability of graft survival, development of corneal neovascularization, and complications. RESULTS: The postoperative follow-up time was 14.3 months (range, 2-62 mo). The cumulative graft survival time was significantly longer in the treatment group than that in the control group (42.9 ± 5.9 vs. 4.8 ± 0.7 mo; log rank < 0.001). In the treatment group, 19 of the 26 grafts (73.1%) survived as transparent with a mean follow-up of 18.7 ± 3.0 months. At the end of the follow-up, 4 grafts remained free of neovascularization, 2 developed edema without neovascularization, and 15 remained transparent with a stable ocular surface and some neovascular vessels in the peripheral transplant interface. The other 5 grafts became opaque and neovascularized. In the control group, all grafts became opaque and neovascularized within the follow-up period (5.5 ± 0.7 mo). During the follow-up, a corneal epithelial defect developed in 9 eyes in the treatment group and 7 in the control group. CONCLUSIONS: Early application of subconjunctival bevacizumab after sclerocorneal lamellar keratoplasty can significantly prevent corneal neovascularization and promote graft survival for severe late-stage ocular chemical burns.
Subject(s)
Bevacizumab/administration & dosage , Burns, Chemical/therapy , Corneal Neovascularization/prevention & control , Corneal Transplantation/methods , Eye Burns/therapy , Sclera/transplantation , Administration, Topical , Adolescent , Adult , Angiogenesis Inhibitors/administration & dosage , Burns, Chemical/complications , Burns, Chemical/diagnosis , Corneal Neovascularization/diagnosis , Corneal Neovascularization/etiology , Dose-Response Relationship, Drug , Eye Burns/complications , Eye Burns/diagnosis , Female , Follow-Up Studies , Graft Survival , Humans , Male , Middle Aged , Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors , Retrospective Studies , Time Factors , Time-to-Treatment , Trauma Severity Indices , Treatment Outcome , Young AdultABSTRACT
Inflammation plays an important role in pathological angiogenesis. Receptor-interacting protein 1 (RIP1) is highly expressed in inflammatory cells and is known to play an important role in the regulation of apoptosis, necroptosis, and inflammation; however, a comprehensive description of its role in angiogenesis remains elusive. Here, we show that RIP1 is abundantly expressed in infiltrating macrophages during angiogenesis, and genetic or pharmacological inhibition of RIP1 kinase activity using kinase-inactive RIP1K45A/K45A mice or necrostatin-1 attenuates angiogenesis in laser-induced choroidal neovascularization, Matrigel plug angiogenesis, and alkali injury-induced corneal neovascularization in mice. The inhibitory effect on angiogenesis is mediated by caspase activation through a kinase-independent function of RIP1 and RIP3. Mechanistically, infiltrating macrophages are the key target of RIP1 kinase inhibition to attenuate pathological angiogenesis. Inhibition of RIP1 kinase activity is associated with caspase activation in infiltrating macrophages and decreased expression of proangiogenic M2-like markers but not M1-like markers. Similarly, in vitro, catalytic inhibition of RIP1 down-regulates the expression of M2-like markers in interleukin-4-activated bone marrow-derived macrophages, and this effect is blocked by simultaneous caspase inhibition. Collectively, these results demonstrate a nonnecrotic function of RIP1 kinase activity and suggest that RIP1-mediated modulation of macrophage activation may be a therapeutic target of pathological angiogenesis.
Subject(s)
GTPase-Activating Proteins/physiology , Macrophages/physiology , Neovascularization, Pathologic/enzymology , Animals , Biomarkers , Caspases/metabolism , Cells, Cultured , Collagen , Corneal Injuries/chemically induced , Corneal Injuries/etiology , Corneal Neovascularization/enzymology , Corneal Neovascularization/etiology , Corneal Neovascularization/pathology , Corneal Neovascularization/prevention & control , Drug Combinations , Enzyme Activation , Fibroblast Growth Factor 2/pharmacology , GTPase-Activating Proteins/antagonists & inhibitors , Human Umbilical Vein Endothelial Cells , Humans , Imidazoles/pharmacology , Imidazoles/therapeutic use , In Situ Nick-End Labeling , Indoles/pharmacology , Indoles/therapeutic use , Laminin , Lasers/adverse effects , Macrophages/classification , Mice , Mice, Inbred C57BL , Models, Animal , Neovascularization, Pathologic/pathology , Oligopeptides/pharmacology , Proteoglycans , RNA, Messenger/biosynthesis , Receptor-Interacting Protein Serine-Threonine Kinases/deficiency , Receptor-Interacting Protein Serine-Threonine Kinases/physiology , Receptors, Vascular Endothelial Growth Factor/therapeutic use , Recombinant Fusion Proteins/pharmacology , Recombinant Fusion Proteins/therapeutic useABSTRACT
Sex-based differences in susceptibility have been reported for a number of neovascular ocular diseases. We quantified corneal neovascularization, induced by superficial silver nitrate cautery, in male and female inbred albino Sprague-Dawley, inbred albino Fischer 344, outbred pigmented Hooded Wistar and inbred pigmented Dark Agouti rats of a range of ages. Corneal neovascular area was quantified on haematoxylin-stained corneal flatmounts by image analysis. Pro-and anti-angiogenic gene expression was measured early in the neovascular response by quantitative real-time polymerase chain reaction. Androgen and estrogen receptor expression was assessed by immunohistochemistry. Male rats from all strains, with or without ocular pigmentation, exhibited significantly greater corneal neovascular area than females: Sprague-Dawley males 43±12% (n = 8), females 25±5% (n = 12), p = 0.001; Fischer 344 males 38±10% (n = 12) females 27±8% (n = 8) p = 0.043; Hooded Wistar males 32±6% (n = 8) females 22±5% (n = 12) p = 0.002; Dark Agouti males 37±11% (n = 9) females 26±7% (n = 9) p = 0.015. Corneal vascular endothelial cells expressed neither androgen nor estrogen receptor. The expression in cornea post-cautery of Cox-2, Vegf-a and Vegf-r2 was significantly higher in males compared with females and Vegf-r1 was significantly lower in the cornea of males compared to females, p<0.001 for each comparison. These data suggest that male corneas are primed for angiogenesis through a signalling nexus involving Cox-2, Vegf-a, and Vegf receptors 1 and 2. Our findings re-enforce that pre-clinical animal models of human diseases should account for sex-based differences in their design and highlight the need for well characterized and reproducible pre-clinical studies that include both male and female animals.
Subject(s)
Cornea/blood supply , Cornea/metabolism , Corneal Neovascularization/etiology , Animals , Cornea/pathology , Corneal Neovascularization/genetics , Corneal Neovascularization/metabolism , Cyclooxygenase 2/genetics , Disease Models, Animal , Disease Susceptibility , Female , Gene Expression , Male , Rats , Rats, Inbred F344 , Rats, Inbred Strains , Rats, Sprague-Dawley , Rats, Wistar , Receptors, Androgen/metabolism , Receptors, Estrogen/metabolism , Sex Characteristics , Species Specificity , Vascular Endothelial Growth Factor A/genetics , Vascular Endothelial Growth Factor Receptor-1/genetics , Vascular Endothelial Growth Factor Receptor-2/geneticsABSTRACT
PURPOSE: To analyze corneal neovascularization using anterior segment optical coherence tomography angiography (AS-OCTA) in patients following cultivated oral mucosal epithelial sheet transplantation (COMET). DESIGN: Observational case series. METHODS: Nine eyes in 7 patients were analyzed. Four images of corneal quadrant were obtained by AS-OCTA from each patient during follow-up post-COMET in the Department of Ophthalmology at Osaka University Hospital. The depth of corneal neovascularization was evaluated using en face and B-scan images. Each quadrant image was classified as 1 of the following 5 types: stromal, predominantly stromal, epithelial, predominantly epithelial, or avascular. The image quality of slit-lamp photography and AS-OCTA was graded from 0 to 4. Manually segmented images of the epithelial and stromal vessels were obtained. MAIN OUTCOME MEASURES: Depth and image quality of corneal neovascularization following COMET. RESULTS: Six patients were male and 1 was female. The mean patient age was 61.3 ± 19.1 years. Thirty-six quadrant images were obtained, of which 4 (11.1%) were stromal, 16 (44.4%) were predominantly stromal, 3 (8.3%) were epithelial, 11 (30.6%) were predominantly epithelial, and 2 (5.6%) were avascular. The image quality obtained by AS-OCTA was significantly better than that obtained by slit-lamp photography (2.38 ± 0.94 vs 2.03 ± 0.90; P = .021). Segmentation images clearly demonstrated both epithelial and stromal vasculatures individually. CONCLUSIONS: AS-OCTA is useful for evaluation of depth of corneal neovascularization and has the potential to distinguish between conjunctivalization and stromal neovascularization following COMET. Findings on AS-OCTA could contribute to clinical decision making, given that retreatment is required for conjunctivalization after COMET.
Subject(s)
Anterior Eye Segment/diagnostic imaging , Cell Transplantation/adverse effects , Corneal Neovascularization/etiology , Epithelial Cells/transplantation , Mouth Mucosa/cytology , Adult , Aged , Cell Culture Techniques , Corneal Neovascularization/diagnostic imaging , Female , Fluorescein Angiography , Follow-Up Studies , Humans , Limbus Corneae/pathology , Male , Middle Aged , Stem Cells/pathology , Tomography, Optical CoherenceABSTRACT
Following corneal injury, coordinated cellular and protein interactions occur at the wound site to restore tissue homeostasis. Regulation of this response is required to prevent the development of chronic inflammation, abnormal neovascularization, and fibrosis. The chemokine CCL2 and its primary receptor CCR2 are key regulators of the inflammatory and neovascular responses to injury. In this study, we investigated the role of macrophage-associated matrix metalloproteinase 12 (MMP12) in the regulation of CCL2 and CCR2 after corneal wounding. Using two corneal injury models, we examined the temporal and spatial expression of CCL2 and CCR2 in Mmp12-/- and wild-type (WT) mice. Our data showed that MMP12 downregulated CCL2 and CCR2 expression in a manner dependent on the timing and mechanism of injury. We also examined the effect of CCL2 on the injury response in Mmp12-/- and WT corneas. We found that macrophage infiltration and neovascularization following CCL2 blockade was significantly reduced in Mmp12-/- corneas as compared with WT corneas. These findings indicate that MMP12 inhibits corneal inflammation and neovascularization after injury through its regulation of CCL2.